TC Affiliations:
Educational Background
Emory University, Ph.D., Neuroscience
Selected Publications
- Research Papers
Anlys Olivera, Yan Liu, Zuoxin Wang. “Neonatal exposure to amphetamine alters behavior and central dopamine activity in male prairie voles.” (Undergraduate honors thesis in submission to European Journal of Neuroscience, 2007)
Anlys Olivera, Andrew H. Miller and Thaddeus W.W. Pace. The role of the transcription factor nuclear factor kappa B (NF-kB) in depressive symptoms. (In preparation)
Anlys Olivera, Fang Hu, Andrew P. Brown, Hyunsuk Shim, Dennis C. Liotta, Andrew H. Miller and Thaddeus W.W. Pace. EF31, a novel curcumin analog, is a potent inhibitor of the nuclear factor kappa B pathway in mouse RAW264.7 macrophages. (In preparation)
Anlys Olivera, Fang Hu, Drew Johnson, Robert Martin, Andrew H. Miller and Thaddeus W.W. Pace. Bi-phasic CNS cytokine and behavioral response at 6 and 24 hours following peripheral administration of LPS in male C57/BL6 mice. (In preparation)
Anlys Olivera, Fang Hu, Drew Johnson, Robert Martin, Andrew H. Miller and Thaddeus W.W. Pace. The effects of UBS109, a novel NF-kB inhibitor, on LPS-induced depressive-like behaviors in male C57/BL6 mice. (In preparation)
Published Abstract
A. Olivera, F. Hu, A.P. Brown, H. Shim, D.C. Liotta, A.H. Miller, and T.W.W. Pace. 111. The curcumin analog, UBS-109 decreases peripheral expression of LPS-induced inflammatory cytokines. Brain, Behavior, and Immunity. Volume 22, Issue 4, Supplement 1, May 2008, Page 36. PNIRS 2008 - Promoting Innovation in PNI: From Cytokines to Society, 2008 Psychoneuroimmunology Research Society Meeting.
A. Olivera, F. Hu, A.H. Miller and T.W. Pace. 100. UBS109, a novel curcumin analog, is a potent inhibitor of nuclear factor-kappa b activity in mouse RAW264.7 macrophages. Brain, Behavior, and Immunity. Volume 23, Supplement 2, July 2009, Pages S52-S53. PNIRS 2009, PsychoNeuroImmunology Research Society Annual Meeting 2009
A. Olivera, D. Johnson, R. Martin, A.H. Miller, T.W. Pace. 112. Bi-phasic CNS cytokine induction at 6 and 24 h following peripheral administration of LPS. Brain, Behavior, and Immunity. Volume 24, Supplement 21, August 2010, Pages S34-S35. PNIRS 2010 - PsychoNeuroImmunology: Crossing disciplines to combat disease, 17th Annual Meeting of The PsychoNeuroImmunology Research Society
Grants
Ruth L. Kirschstein National Research Fellowship, NIMH, Predoctoral NRSA (F31): Effects of UBS109, a novel NF-kB inhibitor, on depressive-like behaviors
Facilitating Academic Careers in Engineering and Sciences, NIH
Honors and Awards
Academic and Professional Honors
- Florida State University Grant, 2002-2006
- Freshman Incentive Scholarship, 2002-2006
- Florida Bright Futures Medallion Scholarship recipient, 2002-2006
- Gates Millennium Scholar, 2002-present
- President’s List, Florida State University, 2005-2006
- Dean’s List, Florida State University, 2002-2006
- Florida State University Undergraduate Honors Thesis Research Grant, 2005-2006
- Florida State University Featured Undergraduate Student, 2006
- B.S. awarded with honors, Magna Cum Laude, Florida State University, 2006
- FACES Graduate Fellow, Emory University, 2006-present
- Ruth L. Kirschstein National Research Fellow, 2008-present
- Psychoneuroimmunology Research Society Trainee Award, 2009
Professional and Honors Society
- Phi Beta Kappa, 2003-2006
- National Scholars Honor Society Induction, 2003
- Society for Neuroscience, 2005-present
- Psychoneuroimmunology Research Society, 2008-present